Talent
Investor Portal
About
What We Do
FAQs
Sectors
Deep Tech
Life Sciences
Health Tech
Portfolio
Team
News
Contact
Newsroom
latest news from ose
and across our portfolio
Featured News
August 31, 2023
Oxford Science Enterprises Appoints Ed Bussey as Chief Executive Officer
Article links to www.globenewswire.com
September 27, 2023
Sitryx raises additional $39 million to progress development of disease-modifying therapeutics
Article links to prn.to
October 3, 2023
The Oxford-Harrington Rare Disease Centre Launches
Article links to www.beacontx.com
June 12, 2023
Beacon Therapeutics launches with £96 million to develop a new generation of gene therapies for retinal diseases
Article links to innovation.ox.ac.uk
May 22, 2023
Oxford University retains No. 1 spot for spinouts
Article links to www.ultromics.com
April 26, 2023
Ultromics granted FDA Breakthrough Device Designation
Article links to www.caristo.com
April 17, 2023
Caristo Diagnostics Completes Series A Financing and Welcomes New CEO
Article links to quantummotion.tech
February 21, 2023
Quantum Motion Raises £42 Million Investment Round
All News
21•06•24
Portfolio News
PQShield
PQShield raises $37m in Series B funding to deliver the widespread commercial adoption of quantum resistant cryptography
30•05•23
Portfolio News
PQShield
PQShield partners with Tata Consultancy Services and eShard
12•04•23
Portfolio News
PQShield
PQShield collaborates with NCCoE to ease the real-world implementation of quantum-resistant cryptography
04•07•22
Portfolio News
PQShield
PQShield algorithms to be standardised as the National Institute of Standards and Technology (NIST) announces the first international Post-Quantum Cryptography standards
26•01•22
Portfolio News
PQShield
PQShield raises $20 million in Series A funding to fuel global growth
30•09•21
Portfolio News
PQShield
PQShield announces new hires to accelerate business growth
Menu
About
What We Do
FAQs
Sectors
Deep Tech
Life Sciences
Health Tech
Portfolio
Team
News
Contact
Talent
Investor Portal